Purdue Pharma

Stories 21 - 38 | << Prev 

New York AG Uncovers $1B Wired by Sackler Family

Transfers boost suspicions that owners of OxyContin maker Purdue tried to shield wealth

(Newser) - The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York's attorney general contends in court papers filed Friday. New York—asking a judge to enforce subpoenas of companies, banks, and advisers to Purdue and its owners, the...

Tentative Deal Reached in Purdue Pharma Lawsuits

OxyContin maker reaches tentative settlement with some of the states, governments suing

(Newser) - A tentative settlement announced Wednesday over the role Purdue Pharma played in the nation's opioid addiction crisis falls short of the far-reaching national settlement the OxyContin maker had been seeking for months, with litigation sure to continue against the company and the family that owns it. The agreement with...

Report: OxyContin Maker in Talks to Settle State Lawsuits

Source say Purdue has offered up to $12B

(Newser) - State attorneys general and lawyers representing local governments said Tuesday they are in active settlement talks with Purdue Pharma, the maker of the prescription painkiller OxyContin that is facing billions of dollars in potential liability for its role in the nation's opioid crisis. Purdue has been cast by attorneys...

Arizona Has Interesting Idea in Fight Against Opioids

State files lawsuit against Sackler family directly with the Supreme Court

(Newser) - The latest lawsuit filed against the Sackler family, billionaire owners of OxyContin maker Purdue Pharma, is being called "novel" and "audacious" by the New York Times and "highly unusual" by the Hill —because it was filed directly with the highest court in the land. Arizona is...

Louvre Covers Sackler Family Name With Tape

It's first major institution to remove the name

(Newser) - France's Louvre Museum in Paris has become the first major institution to remove the Sackler family name after protests erupted against the family that is blamed for the deadly opioid crisis in the US. At the Louvre's Oriental Antiquities gallery, an AP photographer late Wednesday saw tape covering...

For Lawyers in Landmark Opioid Trial, It&#39;s Personal
Landmark Opioid Trial 
Hinges on a Legal Term
the rundown
May 28, 2019 1:08 PM CDT

Landmark Opioid Trial Hinges on a Legal Term

What is a 'public nuisance'?

(Newser) - A landmark trial got underway Tuesday in Oklahoma—the first big test of whether a state can hold drug manufacturers responsible for the opioid crisis, reports the Wall Street Journal . In opening arguments, Attorney General Mike Hunter said these painkillers have led to the "worst manmade public health crisis"...

For OxyContin Maker: $270M Settlement, Potential Bankruptcy

Purdue Pharma settles suit with Oklahoma for $270M

(Newser) - The maker of OxyContin has agreed to pay $270 million to resolve claims in Oklahoma that it helped fuel the opioid crisis and thereby contributed to thousands of overdose deaths, multiple news outlets are reporting. Oklahoma Attorney General Mike Hunter, who sued 13 opioid manufacturers for promoting opioids as safe...

OxyContin Exec Boasted of 'Blizzard of Prescriptions'

Sackler accused of misleading public about dangers of addiction

(Newser) - Some of the seeds of today's opioid crisis were sown at the 1995 launch party of OxyContin, where Purdue Pharma exec Richard Sackler promised "a blizzard of prescriptions that will bury the competition," according to a memo filed by Massachusetts Attorney General Maura Healey. She accuses Sackler...

Guy Behind OxyContin Breaks the Irony Record

Richard Sackler is named as an inventor of new anti-opioid drug

(Newser) - Irony alert: A billionaire accused of worsening the opioid crisis just won a patent for a drug to treat opioid addiction, Stat News reports. Richard Sackler, whose family owns OxyContin-maker Purdue Pharma, is one of six inventors behind a new medication that could help people get off drugs including opioids....

Artist Makes a Point Outside Drugmaker's Headquarters

Domenic Esposito tries to shame OxyContin maker Purdue Pharma with giant spoon

(Newser) - An 800-pound, nearly 11-foot-long steel sculpture of a bent and burned drug spoon was placed Friday in front of the Connecticut headquarters of drugmaker Purdue Pharma as part of an art protest against the opioid crisis. Artist Domenic Esposito and art gallery owner Fernando Alvarez placed the sculpture at the...

OxyContin Maker Kept a Dark Secret: Confidential Report
OxyContin Maker Kept a Dark
Secret: Confidential Report
in case you missed it
Jun 2, 2018 6:30 AM CDT

OxyContin Maker Kept a Dark Secret: Confidential Report

Execs knew early that patients were abusing drug, says New York Times

(Newser) - The company behind OxyContin may have a little secret—that it knew early on about people abusing its powerful painkilling drug and said nothing, the New York Times reports. Purdue Pharma executives received reports of "significant" abuse soon after Oxycontin's 1996 release, including people stealing and snorting the...

OxyContin Maker Ends Industry-Changing Strategy

Purdue Pharma will no longer promote the painkiller to doctors

(Newser) - The medical website STAT sees it as the "end of an era"—the maker of OxyContin is going to stop promoting the opioid to doctors. As Bloomberg reports, Purdue Pharma is cutting its sales staff in half to 200 employees and will no longer send representatives to doctors'...

Maker of OxyContin Sued by Drug-Addled City

Complaint filed by Everett, Wash., says Purdue Pharma valued profits over people

(Newser) - What does a city do when its citizens are wracked with opioid addiction? Sue the maker of one of the most well-known brands is the route Everett is taking, the Los Angeles Times reports. The Washington city of 100,000 north of Seattle filed a complaint Thursday against Purdue Pharma,...

11-Year-Olds Can Now Be Prescribed OxyContin

FDA approves drug for severe pain in kids 11 to 16

(Newser) - The FDA has approved the powerful painkiller OxyContin for a new use in children 11 to 16 who are suffering from severe, long-term pain. OxyContin is an extended-release opioid that has long been used to treat around-the-clock pain in adults. But most pain medications are not approved for use in...

Combo Painkiller Designed to Be Tougher to Abuse

FDA approves opioid that won't cause euphoria when crushed

(Newser) - The FDA has approved a new form of OxyContin that unites two unlikely bedfellows in an attempt to curb abuse, reports AP . The drug from Purdue Pharma is called Targiniq ER, and it combines oxycodone—the main painkilling ingredient in OxyContin, one that causes feelings of euphoria—with naloxene, which...

Oxy Maker Won't Share List of Suspicious Doctors

Purdue Pharma has IDed 1,800 suspect doctors, but only told authorities about 154

(Newser) - The maker of OxyContin has a database of doctors it suspects may be prescribing its pills to addicts and dealers—but it isn't sharing that info with cops, reports the LA Times . Purdue Pharma says it has alerted authorities to 154 suspicious prescribers, but that's only about 8%...

FDA Blocks Generic OxyContin
  FDA Blocks Generic OxyContin 
Apr 17, 2013 4:01 AM CDT

FDA Blocks Generic OxyContin

Move prevents crushable form returning to market

(Newser) - In a big victory for campaigners against prescription drug abuse—as well as for OxyContin maker Purdue Pharma—the FDA has blocked generic drugmakers from making their own versions of the powerful painkiller. The ruling came on the day that Purdue's patent on the old, crushable, and widely abused...

OxyContin Maker Pleads Guilty
OxyContin Maker Pleads Guilty
May 10, 2007 12:01 PM CDT

OxyContin Maker Pleads Guilty

Manufacturer, execs admit misleading public about risky painkiller

(Newser) - The company that makes OxyContin pleaded guilty today to misleading the public about the effects of the potent painkiller. Purdue Pharma and three executives will pay $634.5 million in civil and criminal fines. Federal prosecutors accused the firm of "misbranding" the drug, marketing it as a less addictive...

Stories 21 - 38 | << Prev